{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T08:04:57Z","timestamp":1747123497501},"reference-count":68,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[1995,12,1]],"date-time":"1995-12-01T00:00:00Z","timestamp":817776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[1995,12]]},"DOI":"10.1016\/0959-8049(95)00367-3","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T19:06:17Z","timestamp":1027623977000},"page":"2141-2145","source":"Crossref","is-referenced-by-count":17,"title":["Non-Hodgkin's lymphomas\u2014current status of therapy and future perspectives"],"prefix":"10.1016","volume":"31","author":[{"given":"W.","family":"Hiddemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0959-8049(95)00367-3_BIB1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas","volume":"I","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/0959-8049(95)00367-3_BIB2","series-title":"Histopathology of Non-Hodgkin's Lymphomas (Based on the Updated Kiel Classification)","author":"Lennert","year":"1992"},{"key":"10.1016\/0959-8049(95)00367-3_BIB3","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00367-3_BIB4","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A proposal for an international consensus on the classification of lymphoid neoplasms","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1016\/0959-8049(95)00367-3_BIB5","first-page":"485","article-title":"Strategien der Behandlung von Non-Hodgkin Lymphomen","volume":"27","author":"Brittinger","year":"1986","journal-title":"Internist"},{"key":"10.1016\/0959-8049(95)00367-3_BIB6","first-page":"1023","article-title":"Treatment of non-Hodgkin's lymphoma","volume":"328","author":"Armitage","year":"1992","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/0959-8049(95)00367-3_BIB7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/annonc\/5.suppl_2.S23","article-title":"Low-grade lymphoma 1993: state of the art","volume":"5","author":"Horning","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0268-960X(94)90110-4","article-title":"Current status and future perspectives in the treatment of low-grade non-Hodgkin's lymphomas","author":"Hiddemann","year":"1994","journal-title":"Blood Rev"},{"key":"10.1016\/0959-8049(95)00367-3_BIB9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-104-6-757","article-title":"Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD","volume":"104","author":"Shipp","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/0959-8049(95)00367-3_BIB10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1986.4.6.859","article-title":"Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma","volume":"4","author":"Jagannath","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB11","first-page":"5372","article-title":"Predictive model for prognosis in advanced diffuse histiocytic lymphoma","volume":"46","author":"Danieu","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/0959-8049(95)00367-3_BIB12","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1200\/JCO.1989.7.10.1518","article-title":"A new serologic staging system for large-cell lymphomas based on initial \u03b22-microglobulin and lactate dehydrogenase levels","volume":"7","author":"Swan","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1200\/JCO.1991.9.2.211","article-title":"Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy; The Groupe d'\u00c9tudes des Lymphomes Agressifs","volume":"9","author":"Coiffier","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB14","first-page":"127","article-title":"Klinisch relevante Prognosefaktoren maligner Lymphome","volume":"34","author":"Engelhard","year":"1993","journal-title":"Internist"},{"key":"10.1016\/0959-8049(95)00367-3_BIB15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1172\/JCI113598","article-title":"HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma","volume":"82","author":"Miller","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/0959-8049(95)00367-3_BIB16","first-page":"375a","article-title":"Beta-2-microglobulin (\u03b22M) and HLA-DR cellular expression in relapsing large cell lymphomas (LCL): relationship to survival and serum \u03b22M levels","volume":"76","author":"Swan","year":"1990","journal-title":"Blood"},{"key":"10.1016\/0959-8049(95)00367-3_BIB17","first-page":"981","article-title":"Development of a predictive model for aggressive lymphoma: the International non-Hodgkin's lymphoma prognostic factors project","volume":"329","author":"Shipp","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/0959-8049(95)00367-3_BIB18","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1200\/JCO.1994.12.7.1340","article-title":"Is the international prognostic index for aggressive lymphoma patients useful for follicular lymphoma patients?","volume":"12","author":"Bastian","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB19","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.1994.12.7.1343","article-title":"Applicability of the international index for aggressive lymphomas to patients with low-grade lymphomas","volume":"12","author":"Lopez-Guillermo","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood.V71.4.1157.1157","article-title":"Independent prognostic significance of nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67","volume":"71","author":"Grogan","year":"1988","journal-title":"Blood"},{"key":"10.1016\/0959-8049(95)00367-3_BIB21","first-page":"6608","article-title":"Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma","volume":"48","author":"Wooldridge","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/0959-8049(95)00367-3_BIB22","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood.V58.6.1218.1218","article-title":"Survival of patients with localized diffuse histiocytic lymphoma","volume":"58","author":"Sweet","year":"1981","journal-title":"Blood"},{"key":"10.1016\/0959-8049(95)00367-3_BIB23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-107-1-25","article-title":"Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma","volume":"1107","author":"Connors","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/0959-8049(95)00367-3_BIB24","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1200\/JCO.1989.7.9.1186","article-title":"Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy","volume":"7","author":"Jones","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB25","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1200\/JCO.1989.7.9.1295","article-title":"Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy","volume":"7","author":"Longo","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1200\/JCO.1993.11.4.720","article-title":"Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphoma","volume":"11","author":"Tondini","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB27","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/1097-0142(197610)38:4<1484::AID-CNCR2820380407>3.0.CO;2-I","article-title":"Hydroxydaunomycin (adriamycin) combination chemotherapy in malignant lymphoma","volume":"38","author":"McKelvey","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00367-3_BIB28","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/0959-8049(95)00367-3_BIB29","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/blood.V82.8.2329.2329","article-title":"Randomized, double-blind, placebo-controlled phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas","volume":"82","author":"Gerhartz","year":"1993","journal-title":"Blood"},{"key":"10.1016\/0959-8049(95)00367-3_BIB30","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood.V80.6.1430.1430","article-title":"Granulocyte colony stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma. A randomized controlled trial","volume":"80","author":"Pettengel","year":"1992","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/0959-8049(95)00367-3_BIB31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/annonc\/5.suppl_2.S134","article-title":"Haemopoietic growth factors and dose intensity in high-grade and intermediate grade lymphoma","volume":"5","author":"Pettengel","year":"1994","journal-title":"Ann Oncol"},{"issue":"Suppl. 1","key":"10.1016\/0959-8049(95)00367-3_BIB32","first-page":"85a","volume":"82","author":"Zittoun","year":"1993","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/0959-8049(95)00367-3_BIB33","first-page":"87a","article-title":"Comparison of autologous bone marrow transplantation (ABMT) with sequential chemotherapy for aggressive non-Hodgkin's lymphoma (NHL) in first complete remission: a study on 464 patients (LNH87 protocol)","volume":"82","author":"Haioun","year":"1993","journal-title":"Blood"},{"key":"10.1016\/0959-8049(95)00367-3_BIB34","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1200\/JCO.1993.11.10.1846","article-title":"High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma","volume":"11","author":"Vose","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/10428199209064898","article-title":"High-dose cyclophosphamide, etoposide, and BCNU with non-cryopreserved autologous bone marrow transplantation for poor prognosis malignant lymphoma","volume":"6","author":"K\u00f6ppler","year":"1992","journal-title":"Leukemia Lymphoma"},{"key":"10.1016\/0959-8049(95)00367-3_BIB36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0167-8140(85)80086-4","article-title":"Role of radiation therapy in localized non-Hodgkin's lymphoma","volume":"4","author":"Sutcliffe","year":"1985","journal-title":"Radiother Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.2900070102","article-title":"Management of localized non-Hodgkin's lymphoma: the experience at St Bartholomew's Hospital 1972\u20131985","volume":"7","author":"Richards","year":"1989","journal-title":"Hematol Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB38","first-page":"66","article-title":"Stage I\u2013II low grade non-Hodgkin's lymphoma: prognostic factors and treatment results","volume":"168","author":"Epelbaum","year":"1992","journal-title":"Strahlenth Onkol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB39","first-page":"R115","article-title":"Non-Hodgkin lymphomas (NHL)\u2014early stage interim results of a multicentre trial","volume":"118","author":"Sack","year":"1992","journal-title":"Cancer Res Clin Oncol"},{"issue":"Suppl. 2","key":"10.1016\/0959-8049(95)00367-3_BIB40","first-page":"137","article-title":"Stage I\u2013II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy","author":"McLaughlin","year":"1991","journal-title":"Ann Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19830701)52:1<1::AID-CNCR2820520102>3.0.CO;2-M","article-title":"A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas","volume":"52","author":"Nissen","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00367-3_BIB42","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/1097-0142(19930401)71:7<2342::AID-CNCR2820710728>3.0.CO;2-I","article-title":"Adjuvant cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study","volume":"71","author":"Yahalom","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00367-3_BIB43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1200\/JCO.1993.11.2.218","article-title":"Clinical features and prognosis of follicular large-cell lymphoma: a report from Nebraska Lymphoma study group","volume":"11","author":"Anderson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB44","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood.V83.4.881.881","article-title":"Treatment approaches to the low-grade lymphomas","volume":"83","author":"Horning","year":"1994","journal-title":"Blood"},{"key":"10.1016\/0959-8049(95)00367-3_BIB45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00001622-199409000-00005","article-title":"Management of follicular lymphoma","volume":"6","author":"Rohatiner","year":"1994","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00195368","article-title":"Novantrone in combination with sterecyte (NOSTE) in treatment of unfavourable non-Hodgkin's lymphoma","volume":"6","author":"Landys","year":"1988","journal-title":"New Drugs"},{"issue":"Suppl. 1","key":"10.1016\/0959-8049(95)00367-3_BIB47","first-page":"168a","article-title":"Prednimustine, mitoxantrone (PmM) versus cyclophosphamide, vincristine, prednisone (COP) for the treatment of the advanced low grade non-Hodgkin's lymphoma","volume":"84","author":"Unterhalt","year":"1994","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/0959-8049(95)00367-3_BIB48","first-page":"11","article-title":"The treatment of indolent lymphomas: watchful waiting v. aggressive combined modality treatment","volume":"25","author":"Young","year":"1988","journal-title":"Semin Hematol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.1993.11.2.202","article-title":"What's the deal with follicular lymphomas?","volume":"11","author":"Longo","year":"1993","journal-title":"J Clin Oncol"},{"issue":"Suppl. 2","key":"10.1016\/0959-8049(95)00367-3_BIB50","first-page":"67","article-title":"Chlorambucil\/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central Sweden","volume":"5","author":"Kimby","year":"1994","journal-title":"Am Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB51","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1993.11.4.644","article-title":"Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemo-immunotherapy","volume":"11","author":"Dana","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB52","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199211053271902","article-title":"Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma","volume":"327","author":"Smalley","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/0959-8049(95)00367-3_BIB53","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM199311253292203","article-title":"Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma","volume":"329","author":"Solal-Celigny","year":"1993","journal-title":"N Engl J Med"},{"issue":"Suppl. 4","key":"10.1016\/0959-8049(95)00367-3_BIB54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0277-5379(91)90566-V","article-title":"Randomized study of chlorambucil (CB) compared to interferon (alfa- 2b) combined with CB in low-grade non-Hodgkin's lymphoma: an interim report of a randomized study","volume":"27","author":"Chisesi","year":"1991","journal-title":"Eur J Cancer"},{"issue":"Suppl. 2","key":"10.1016\/0959-8049(95)00367-3_BIB55","first-page":"141","article-title":"Interferon 2b in the treatment of follicular lymphoma: preliminary results of a trial in progress","volume":"2","author":"Price","year":"1991","journal-title":"Ann Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB56","first-page":"366","article-title":"Cyclophosphamide versus cyclophosphamide plus interferon alfa-2b in follicular low grade lymphomas: a preliminary report of an intergroup trial (CALGB 8691 and EST 7486)","volume":"12","author":"Peterson","year":"1993"},{"issue":"Suppl. 1","key":"10.1016\/0959-8049(95)00367-3_BIB57","first-page":"74a","article-title":"Maintenance of remission with human recombinant alpha-2 interferon (Roferon-A) in patients with stages III and IV low grade malignant non-Hodgkin's lymphoma. Results from a prospective, randomised phase III clinical trial in 331 patients","volume":"80","author":"Hagenbeek","year":"1992","journal-title":"Blood"},{"key":"10.1016\/0959-8049(95)00367-3_BIB58","first-page":"32","author":"Hiddemann","year":"1994","journal-title":"Semin Hematol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB59","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1182\/blood.V74.7.2579.2579","article-title":"Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation","volume":"74","author":"Schouten","year":"1989","journal-title":"Blood"},{"key":"10.1016\/0959-8049(95)00367-3_BIB60","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1200\/JCO.1990.8.5.784","article-title":"Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse","volume":"8","author":"Freedman","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB61","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1994.12.6.1177","article-title":"Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma","volume":"12","author":"Rohatiner","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/oxfordjournals.annonc.a059209","article-title":"Purine analogs in the treatment of lowgrade lymphomas and chronic lymphocytic leukemias","author":"Pott","year":"1995","journal-title":"Ann Oncol"},{"issue":"Suppl. 6","key":"10.1016\/0959-8049(95)00367-3_BIB63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-199400476-00008","article-title":"Fludarabine in the management of malignant lymphomas","volume":"47","author":"Hiddemann","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/0959-8049(95)00367-3_BIB64","first-page":"695","article-title":"New antimetabolites in the treatment of human malignancies","volume":"19","author":"Cheson","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB65","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1002\/1097-0142(19931201)72:11+<3470::AID-CNCR2820721614>3.0.CO;2-0","article-title":"The newer purine analogs","volume":"72","author":"Saven","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00367-3_BIB66","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1200\/JCO.1994.12.3.575","article-title":"Phase I study of the combination of fludarabine, mitoxantrone and dexamethasone in low-grade lymphoma","volume":"12","author":"McLaughlin","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00367-3_BIB67","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJM199308123290703","article-title":"Radioimmunotherapy of B-cell lymphoma with 131I anti-B1 (anti-CD20) antibody","volume":"329","author":"Kaminski","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/0959-8049(95)00367-3_BIB68","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJM199310213291702","article-title":"Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support","volume":"329","author":"Press","year":"1993","journal-title":"N Engl J Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0959804995003673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0959804995003673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T21:44:45Z","timestamp":1580247885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0959804995003673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":68,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[1995,12]]}},"alternative-id":["0959804995003673"],"URL":"https:\/\/doi.org\/10.1016\/0959-8049(95)00367-3","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[1995,12]]}}}